Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity A Zhernakova, A Kurilshikov, MJ Bonder, EF Tigchelaar, M Schirmer, ... Science 352 (6285), 565-569, 2016 | 1805 | 2016 |
Proton pump inhibitors affect the gut microbiome F Imhann, MJ Bonder, AV Vila, J Fu, Z Mujagic, L Vork, EF Tigchelaar, ... Gut 65 (5), 740-748, 2016 | 1204 | 2016 |
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases S Sanna, NR van Zuydam, A Mahajan, A Kurilshikov, A Vich Vila, U Võsa, ... Nature genetics 51 (4), 600-605, 2019 | 1136 | 2019 |
Large-scale association analyses identify host factors influencing human gut microbiome composition A Kurilshikov, C Medina-Gomez, R Bacigalupe, D Radjabzadeh, J Wang, ... Nature genetics 53 (2), 156-165, 2021 | 1086 | 2021 |
The effect of host genetics on the gut microbiome MJ Bonder, A Kurilshikov, EF Tigchelaar, Z Mujagic, F Imhann, AV Vila, ... Nature genetics 48 (11), 1407-1412, 2016 | 796 | 2016 |
Impact of commonly used drugs on the composition and metabolic function of the gut microbiota A Vich Vila, V Collij, S Sanna, T Sinha, F Imhann, AR Bourgonje, ... Nature communications 11 (1), 362, 2020 | 573 | 2020 |
Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome A Vich Vila, F Imhann, V Collij, SA Jankipersadsing, T Gurry, Z Mujagic, ... Science translational medicine 10 (472), eaap8914, 2018 | 504 | 2018 |
Cohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics EF Tigchelaar, A Zhernakova, JAM Dekens, G Hermes, A Baranska, ... BMJ open 5 (8), e006772, 2015 | 279 | 2015 |
Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to … Z Mujagic, S Ludidi, D Keszthelyi, MAM Hesselink, JW Kruimel, ... Alimentary pharmacology & therapeutics 40 (3), 288-297, 2014 | 124 | 2014 |
Rome III vs Rome IV criteria for irritable bowel syndrome: a comparison of clinical characteristics in a large cohort study L Vork, ZZRM Weerts, Z Mujagic, JW Kruimel, MAM Hesselink, JWM Muris, ... Neurogastroenterology & Motility 30 (2), e13189, 2018 | 111 | 2018 |
The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial Z Mujagic, P De Vos, MV Boekschoten, C Govers, HJHM Pieters, ... Scientific reports 7 (1), 40128, 2017 | 101 | 2017 |
The enteric nervous system relays psychological stress to intestinal inflammation KM Schneider, N Blank, Y Alvarez, K Thum, P Lundgren, L Litichevskiy, ... Cell 186 (13), 2823-2838. e20, 2023 | 95 | 2023 |
Joosten LAB, Netea MG, Franke L, Zhernakova A, Fu J, Wijmenga C, McCarthy MI. 2019. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases S Sanna, NR van Zuydam, A Mahajan, A Kurilshikov, A Vich Vila, U Võsa, ... Nat Genet 51 (4), 600-605, 0 | 86 | |
Alterations in serotonin metabolism in the irritable bowel syndrome AY Thijssen, Z Mujagic, D Jonkers, S Ludidi, D Keszthelyi, MA Hesselink, ... Alimentary Pharmacology & Therapeutics 43 (2), 272-282, 2016 | 76 | 2016 |
Volatile organic compounds in exhaled air as novel marker for disease activity in Crohn's disease: a metabolomic approach AGL Bodelier, A Smolinska, A Baranska, JW Dallinga, Z Mujagic, ... Inflammatory bowel diseases 21 (8), 1776-1785, 2015 | 71 | 2015 |
Intestinal barrier function is maintained with aging–a comprehensive study in healthy subjects and irritable bowel syndrome patients E Wilms, FJ Troost, M Elizalde, B Winkens, P de Vos, Z Mujagic, ... Scientific reports 10 (1), 475, 2020 | 65 | 2020 |
Markers for visceral hypersensitivity in patients with irritable bowel syndrome S Ludidi, Z Mujagic, D Jonkers, D Keszthelyi, M Hesselink, J Kruimel, ... Neurogastroenterology & Motility 26 (8), 1104-1111, 2014 | 65 | 2014 |
The Experience Sampling Method‐a new digital tool for momentary symptom assessment in IBS: an exploratory study Z Mujagic, C Leue, L Vork, R Lousberg, DMAE Jonkers, D Keszthelyi, ... Neurogastroenterology & Motility 27 (9), 1295-1302, 2015 | 61 | 2015 |
Systematic review: instruments to assess abdominal pain in irritable bowel syndrome Z Mujagic, D Keszthelyi, Q Aziz, W Reinisch, EG Quetglas, ... Alimentary pharmacology & therapeutics 42 (9), 1064-1081, 2015 | 59 | 2015 |
Volatile organic compounds in breath as markers for irritable bowel syndrome: a metabolomic approach A Baranska, Z Mujagic, A Smolinska, JW Dallinga, D Jonkers, ... Alimentary pharmacology & therapeutics 44 (1), 45-56, 2016 | 58 | 2016 |